ClinicalTrialsFinder

BRCA-Mutated Breast Carcinoma Clinical Trials in Shanghai, Shanghai Municipality

1 recruitingShanghai, Shanghai Municipality, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab

HER2-negative Breast CancerBRCA-Mutated Breast Carcinoma
Fudan University130 enrolled1 locationNCT06516289